M&A Deal Summary

Shore Capital Partners Acquires EyeSouth Partners

On March 14, 2017, private equity firm Shore Capital Partners acquired healthcare services company EyeSouth Partners

Acquisition Highlights
  • This is Shore Capital Partners’ 12th transaction in the Healthcare Services sector.
  • This is Shore Capital Partners’ 19th transaction in the United States.
  • This is Shore Capital Partners’ 1st transaction in Georgia.
Investment Fate
  • EyeSouth Partners was sold to a consortium of financial buyers in 2022.

M&A Deal Summary
Date 2017-03-14
Target EyeSouth Partners
Sector Healthcare Services
Buyer(s) Shore Capital Partners
Deal Type Buyout (LBO, MBO, MBI)

Target

EyeSouth Partners

Atlanta, Georgia, United States
website
EyeSouth Partners is an eye care physician services organization committed to partnering with leading physicians to build a premier network of eye care services in Georgia and the Southeast. EyeSouth’s partner practices’ clinical mission is to provide high-quality medical and surgical specialty eye care. The organization supports its affiliated practices and physician partners with capital, administrative resources, operating expertise, and strategic guidance with an absolute focus on clinical quality and a patient-first culture. EyeSouth Partners was formed in 2017 and is based in Atlanta, Georgia.

Search 192,349 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Shore Capital Partners

Chicago, Illinois, United States

Investor Investor Investor Investor Investor

website

Category Private Equity Firm
Founded 2009
PE ASSETS 350M USD
Size Middle-Market
Type Sector Focused
DESCRIPTION

Shore Capital Partners is a private equity group focused on opportunities in healthcare, food/beverages, and business services. Specific healthcare areas of interest include infusion therapy, laboratory services, laboratory products/distribution, outpatient rehab therapy, and behavioral health. Shore looks to invest in proven businesses with stable cash-flows and 'significant' growth potential. Prospective companies typically have $5 to $50 million in sales and $1 to $7 million of EBITDA. Shore Capital was formed in 2009 and is based in Chicago, Illinois.

DEAL STATS #
Overall 19 of 50
Sector (Healthcare Services) 12 of 26
Type (Buyout (LBO, MBO, MBI)) 9 of 18
State (Georgia) 1 of 3
Country (United States) 19 of 49
Year (2017) 2 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-01-25 Argentum

Geneva, Illinois, United States

Argentum is a manufacturer and sells innovative wound care products across a wide number of clinical applications, including the Silverlon® (“Silverlon”) brand, its rapidly-growing, proprietary range of silver-based antimicrobial products. The core platform technology in Silverlon is a uniquely designed silver-plated nylon matrix that provides the powerful antimicrobial properties of silver ions in the dressing without staining the skin and without increasing bioburden. Silverlon dressings are used today by surgeons and other healthcare professionals around the world on surgical wounds, burns, chronic wounds, IV catheter-related wounds, and for negative pressure wound therapy. Argentum was founded in 2001 and is based in Geneva, Illinois.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-06-05 Behavioral Innovations

Addison, Texas, United States

Behavioral Innovations provides center-based and in-home applied behavior analysis therapy (“ABA”), speech therapy (“SLP”) and occupational therapy (“OT”) services to children ages birth through 18 with autism spectrum disorder and other related developmental disabilities. In addition, BI offers adult services in community-based treatment settings. Behavioral Innovations has 13 centers in central and northern Texas and in-home services in the Oklahoma City, OK area.

Buy -
Mergr

Product

Company

Legal